Missing/wrong data?
Log in to edit
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity
scientific article published on April 2007
Author/s
author: John C. Byrd, Michael A Caligiuri, Michael R Grever, Carolyn Cheney, Thomas Lin Pedersen, Syed-Rehan A Hussain
Work details
Publication date
April 1, 2007
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.